Link Pharma Chem Ltd

Link Pharma Chem Other Announcement

Link Pharma Chem Ltd filed a periodic non-applicability notice for Reg 23(9) RPT disclosure. The company's paid-up capital and net worth fall below LODR thresholds, so no disclosure is required.

Link Pharma Chem Q2 FY27 Results: Net Loss of ₹0.2 Cr

Link Pharma Chem approved unaudited results for the quarter and half year ended 30 September 2026. Revenue was Rs.533.13 Lakh with a loss of Rs.22.31 Lakh for the quarter.

Key figure

Net loss ₹0.2 Cr

Link Pharma Chem Board Meeting Date

Link Pharma Chem's board meets on 3 November 2026 to approve unaudited half-year results. The trading window stays closed until results are declared.

Link Pharma Chem Other Announcement

Link Pharma Chem Ltd has filed its quarterly shareholding pattern as mandated by SEBI regulations. This routine disclosure provides the updated ownership structure for the company.

Link Pharma Chem Legal & Regulatory

Link Pharma Chem Ltd received a GST order reducing the total demand and penalty for FY 2021-22. The company plans to appeal the decision.

Value

₹0.18 Cr